Congestive Heart Failure: Clinical Trials

71 trials for Congestive Heart Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

49 completed, 7 terminated, 7 unknown, 5 withdrawn. 71 Phase 2, 19 Phase 1, 12 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 271Completed 49, Terminated 7, Unknown 7, Withdrawn 5, Recruiting 2, Active not recruiting 1
Phase 119Completed 10, Unknown 3, Recruiting 2, Terminated 2, Withdrawn 2
Phase 312Completed 8, Unknown 3, Withdrawn 1

Follow Congestive Heart Failure: new trials by email Literature Review of Congestive Heart Failure trials Research Report on Congestive Heart Failure

Trials (filtered) newest first · largest first

All 71 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Peritoneal Ultrafiltration in Cardio Renal Syndrome.
PolyCore (Polydextrin, L-Carnitine, D-xylitol) - Congestive Heart Failure
Phase 1 / Phase 2RecruitingIperboreal Pharma Srl842025-04-162025-05-16
Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure
AB-1002 - Congestive Heart Failure
Phase 2Active not recruitingAskBio Inc1502023-10-202025-12-03
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
SRD-001, Placebo - Congestive Heart Failure, Heart Failure, Systolic
Phase 1 / Phase 2RecruitingSardocor Corp.572021-09-232024-03-26
Acupuncture for the Treatment of Medication-Dependent Hypotension in Heart Failure
True Acupuncture, Sham Acupuncture - Congestive Heart Failure, Hypotension
Phase 1 / Phase 2UnknownScripps Health402021-04-202021-07-07
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic
BMS-986231, Furosemide, Placebo - Cardiac Failure, Myocardial Failure
Phase 2CompletedBristol-Myers Squibb232019-01-172021-02-26
Accessing Mobility Using Wearable Sensors
Exercise - COPD, Pulmonary Disease
Phase 1 / Phase 2WithdrawnBaylor College of Medicine2018-05-212025-08-27
Regression of Fibrosis & Reversal of Diastolic Dysfunction in HFpEF Patients Treated With Allogeneic CDCs
Allogeneic Derived Cells, Placebo/Control Arm - Congestive Heart Failure, Heart Failure, Diastolic
Phase 2CompletedCedars-Sinai Medical Center272017-07-122024-07-25
Sub-Q Versus IV Furosemide in Acute Heart Failure
Furosemide Injection Solution (SCP-101), Furosemide Injection Solution, USP - Congestive Heart Failure
Phase 2 / Phase 3CompletedJohns Hopkins University402016-02-012017-12-18
The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective Trial
fentanyl - Dyspnea, Congestive Heart Failure
Phase 2CompletedSt. Boniface Hospital82015-10-012017-09-28
Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure
D-ribose, Placebo - Congestive Heart Failure
Phase 2WithdrawnRiboCor, Inc.2013-07-012016-07-14
Study of the Acute Effects of Triheptanoin in Heart Failure
Triheptanoin oil - Congestive Heart Failure, Non-ischemic Cardiomyopathy
Phase 1 / Phase 2WithdrawnUniversity of Texas Southwestern Medical Center2013-02-012018-12-14
Vitamin D3 Supplementation for Heart Failure Patients
Placebo Comparator: Sugar Pill, Vitamin D3 (cholecalciferol) - Heart Failure, Vitamin D Deficiency
Phase 2CompletedHeidi Moretti, MS, RD402012-08-012017-04-26
Autonomic Neural Regulation Therapy to Enhance Myocardial Function in Heart Failure (ANTHEM-HF) Study
Vagus Nerve Stimulation (VNS) - Congestive Heart Failure
Phase 1 / Phase 2CompletedCyberonics, Inc.602012-07-012015-02-19
Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure
Nesiritide, Tadalafil, Placebo - Congestive Heart Failure
Phase 1 / Phase 2CompletedMayo Clinic432012-02-012018-03-22
Vasodilator Therapy for Heart Failure and Preserved Ejection Fraction
Isosorbide Dinitrate, Isosorbide Dinitrate + Hydralazine, Placebo - Heart Failure, Congestive Heart Failure
Phase 2CompletedCorporal Michael J. Crescenz VA Medical Center442012-01-012022-06-21
Liraglutide and Heart Failure in Type 2 Diabetes
liraglutide, glimepiride, Metformin - Congestive Heart Failure, Type 2 Diabetes Mellitus
Phase 2CompletedThomas Nystrom622012-01-012016-09-01
Comparative Study of Cardiopulmonary Exercise Test Land Versus Water
Aerobic and anaerobic capacity use aquatic exercises - Congestive Heart Failure
Phase 2 / Phase 3UnknownUniversity of Sao Paulo General Hospital902011-04-012011-04-28
Feasibility Study of BMAC Enhanced CABG
BMAC, CABG only - Congestive Heart Failure
Phase 1 / Phase 2TerminatedHarvest Technologies52011-02-012016-01-18
Blood Pressure Reduction in Heart Failure
Hydralazine/amlodipine, Placebo - Heart Failure, Cardiac Failure
Phase 2 / Phase 3CompletedUniversity of Sao Paulo212011-01-012014-06-10
Bosentan for Severe Mitral Valve Dysfunction
BOSENTAN - SECONDARY PULMONARY HYPERTENSION, MITRAL STENOSIS
Phase 1 / Phase 2UnknownGeneral Hospital of Chalkida102010-12-012011-01-28

Showing 20 of 71. Sign in to see all of them.

Narrower conditions

Heart Failure (71)  ·  Diabetes Mellitus (6)  ·  Renal Insufficiency (5)  ·  Myocardial Infarction (4)  ·  Cardiomyopathies (3)  ·  Myocardial Ischemia (3)  ·  Pulmonary Disease, Chronic Obstructive (3)  ·  Anemia (2)  ·  Cardiovascular Diseases (2)  ·  Heart Diseases (2)  ·  Hyperglycemia (2)  ·  Hypertension (2)  ·  Adenoviridae Infections (1)  ·  Angina Pectoris (1)  ·  Angina, Unstable (1)

Broader conditions

Cardiovascular Diseases (69)  ·  Heart Diseases (69)  ·  Pathological Conditions, Signs and Symptoms (11)  ·  Nutritional and Metabolic Diseases (9)  ·  Pathologic Processes (9)  ·  Vascular Diseases (9)  ·  Glucose Metabolism Disorders (8)  ·  Metabolic Diseases (8)  ·  Endocrine System Diseases (7)  ·  Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Kidney Diseases (6)  ·  Male Urogenital Diseases (6)  ·  Urogenital Diseases (6)  ·  Urologic Diseases (6)

Interventions

Natriuretic Peptide, Brain (6)  ·  Darbepoetin alfa (2)  ·  Furosemide (2)  ·  Hydralazine (2)  ·  Saline Solution (2)  ·  Sodium Chloride (2)  ·  Tolvaptan (2)  ·  5-(formyl-(3-(formyl-(3,5-bis (2,3-dihydroxypropylcarbamoyl)-2,4,6-triiodophenyl) amino)-2-hydroxypropyl)amino)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide (1)  ·  Acupuncture Therapy (1)  ·  Albuterol (1)  ·  Allopurinol (1)  ·  Amlodipine (1)  ·  BAY 58-2667 (1)  ·  Bosentan (1)  ·  Cardiac Resynchronization Therapy (1)

Sponsors

Boston Scientific Corporation (3)  ·  Amgen (2)  ·  Harvest Technologies (2)  ·  Horng Chen (2)  ·  Johns Hopkins University (2)  ·  Kathleen Dungan (2)  ·  Otsuka Pharmaceutical Development & Commercialization, Inc. (2)  ·  Scios, Inc. (2)  ·  US Department of Veterans Affairs (2)  ·  Advanz Pharma (1)  ·  Allina Health System (1)  ·  AskBio Inc (1)  ·  AstraZeneca (1)  ·  Barnes-Jewish Hospital (1)  ·  Bayer (1)

Countries

United States (47)  ·  Canada (7)  ·  Germany (6)  ·  United Kingdom (5)  ·  Italy (3)  ·  Poland (3)  ·  Belgium (2)  ·  Brazil (2)  ·  Denmark (2)  ·  Hungary (2)  ·  India (2)  ·  Spain (2)  ·  Sweden (2)  ·  Australia (1)  ·  Austria (1)

Top investigators

Amit Patel, MD (2)  ·  Horng H. Chen, M.D. (2)  ·  Kathleen M Dungan, MD (2)  ·  Andreas M Zeiher, MD (1)  ·  Anitha Vijayan, M.D. (1)  ·  Anju Nohria, MD (1)  ·  Aslan T Turer, MD, MHS (1)  ·  Bijan Najafi, PhD (1)  ·  Boris Nasseri, MD (1)  ·  Bradley D Berry, MD (1)

Results publications

PMID 15152059, PMID 15319045, PMID 16796497, PMID 17543634, PMID 18549913, PMID 19204305, PMID 19567409, PMID 19919976, PMID 20008582, PMID 20090057, PMID 20154234, PMID 21411144, PMID 22156953, PMID 22361399, PMID 22510424, PMID 22651239, PMID 22728580, PMID 22778174, PMID 22893340, PMID 22936827, PMID 22980293, PMID 23122795, PMID 23487543, PMID 23592107, PMID 23922063, PMID 24497345, PMID 24626998, PMID 25187002, PMID 25319879, PMID 25926562, PMID 26601770, PMID 27221316, PMID 27437887, PMID 28219917, PMID 29084522, PMID 29226816, PMID 29236912, PMID 29548934, PMID 30764699, PMID 31168885, PMID 31909303, PMID 33590355, PMID 34405565, PMID 34920733, PMID 35360224, PMID 35490339, PMID 37349083

NIH funding

P01HL076611 (3), UL1RR024150 (3), R01HL084155 (2), 2004 (1), 2005 (1), 2018 (1), K23DK080891 (1), P01HL066941 (1), R01HL036634 (1), R01HL061912 (1), R21AG043802 (1), R21DK081877 (1)